Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
11 studies found for:    CYBB
Show Display Options
Rank Status Study
1 Completed Sex-specific Association With Kidney Disease
Condition: Diabetic Nephropathy
Intervention:
2 Completed Gene Therapy for X-linked Chronic Granulomatous Disease (CGD) in Children
Condition: Chronic Granulomatous Disease
Intervention: Genetic: retroviral SF71-gp91phox transduced CD34+ cells
3 Unknown  Gene Therapy for Chronic Granulomatous Disease
Condition: Granulomatous Disease, Chronic
Intervention: Drug: retroviral SF71-gp91phox transduced CD34+ cells
4 Recruiting Generation of Powerful Biological Tools for Understanding the Pathophysiology of Chronic Granulomatous Disease.
Condition: Chronic Granulomatous Disease
Intervention: Other: samples collection : hair and skin biopsy
5 Withdrawn Lentiviral Gene Therapy for X-Linked Chronic Granulomatous Disease (X-CGD)
Condition: Granulomatous Disease, Chronic, X-linked, Variant
Intervention: Genetic: pCCLchimGp91s lentiviral vector transduced CD34+ cells infusion
6 Terminated Gene Therapy for Chronic Granulomatous Disease
Condition: Chronic Granulomatous Disease
Intervention: Drug: Phagocyte Oxidase Subunit Transduced CD34 Hematopoietic Stem Cells
7 Recruiting Gene Therapy for X-CGD
Condition: X-linked Chronic Granulomatous Disease
Intervention: Genetic: ex-vivo gene-therapy
8 Active, not recruiting Atorvastatin, Aspirin, Oxidative Stress, Coagulation and Platelet Activation Indexes
Conditions: Type 2 Diabetes Mellitus;   Hypercholesterolemia
Interventions: Drug: Atorvastatin;   Drug: Placebo
9 Recruiting Potential Biomarkers of the Severity of Endothelial Damage in End-stage Chronic Kidney Failure
Condition: End-stage Chronic Kidney Failure
Interventions: Biological: Blood sample;   Other: Retinal photography:;   Other: dialyse
10 Recruiting Gene Therapy for X-linked Chronic Granulomatous Disease
Condition: X-Linked Chronic Granulomatous Disease
Intervention: Genetic: X vivo gene therapy
11 Recruiting Gene Therapy for X-linked Chronic Granulomatous Disease (X-CGD)
Condition: X-Linked Chronic Granulomatous Disease
Intervention: Genetic: X vivo gene therapy

Study has passed its completion date and status has not been verified in more than two years.